Bausch Health Companies (BHC) Operating Expenses (2009 - 2026)
Bausch Health Companies (BHC) reported Operating Expenses of $3.5 billion for Q1 2026, up 75.19% on a YoY basis from $2.0 billion in Q1 2025, and up 49.61% sequentially from $2.3 billion in Q4 2025.
Bausch Health Companies (BHC) Operating Expenses (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Operating Expenses data on file, last reported at $3.5 billion in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses rose 75.19% year-over-year to $3.5 billion; the trailing twelve-month figure through Mar 2026 stood at $9.9 billion (up 21.42% YoY), and the FY2025 full-year result was $8.5 billion, up 4.63% from the prior year.
- Operating Expenses rose to $3.5 billion in Q1 2026, from $2.3 billion in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $3.5 billion in Q1 2026 to a low of $1.6 billion in Q1 2022.
- A 5-year average of $2.1 billion and a median of $2.0 billion in 2024 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses decreased 27.36% in 2022 and jumped 75.19% in 2026, its largest moves.
- Tracing BHC's Operating Expenses over 5 years: stood at $2.4 billion in 2022, then decreased by 15.77% to $2.0 billion in 2023, then slipped by 2.2% to $2.0 billion in 2024, then gained by 16.04% to $2.3 billion in 2025, then jumped by 49.61% to $3.5 billion in 2026.
- Business Quant data shows BHC's Operating Expenses at $3.5 billion in Q1 2026, $2.3 billion in Q4 2025, and $2.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 455.70 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Bausch Health Companies | 1.65 Bn | 333.91 Mn | 2.52 Bn | 3.47 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.47 Bn |
| Dec 31, 2025 | 2.32 Bn |
| Sep 30, 2025 | 2.06 Bn |
| Jun 30, 2025 | 2.09 Bn |
| Mar 31, 2025 | 1.98 Bn |
| Dec 31, 2024 | 2.00 Bn |
| Sep 30, 2024 | 2.19 Bn |
| Jun 30, 2024 | 2.01 Bn |
| Mar 31, 2024 | 1.87 Bn |
| Dec 31, 2023 | 2.05 Bn |
| Sep 30, 2023 | 2.22 Bn |
| Jun 30, 2023 | 1.76 Bn |
| Mar 31, 2023 | 1.77 Bn |
| Dec 31, 2022 | 2.43 Bn |
| Sep 30, 2022 | 1.80 Bn |
| Jun 30, 2022 | 1.81 Bn |
| Mar 31, 2022 | 1.63 Bn |
| Dec 31, 2021 | 1.83 Bn |
| Sep 30, 2021 | 1.54 Bn |
| Jun 30, 2021 | 2.37 Bn |